Trial Profile
Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2021
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Cardiovascular disorders
- Focus Pharmacodynamics
- 06 Aug 2012 New trial record